Works matching IS 19466234 AND DT 2011 AND VI 3 AND IP 95
Results: 7
Rare Copy Number Variation Discovery and Cross- Disorder Comparisons Identify Risk Genes for ADHD.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 95, p. 1, doi. 10.1126/scitranslmed.3002464
- By:
- Publication type:
- Article
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 95, p. 1, doi. 10.1126/scitranslmed.3002842
- By:
- Publication type:
- Article
A Correction to the Focus Titled: "Type 1 Diabetes Immunotherapy: Is the Glass Half Empty or Half Full?" by K. C. Herold and J. A. Bluestone.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 95, p. 1
- Publication type:
- Article
Type 1 Diabetes Immunotherapy: Is the Glass Half Empty or Half Full?
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 95, p. 1, doi. 10.1126/scitranslmed.3002981
- By:
- Publication type:
- Article
Curaxins: Anticancer Compounds that Simultaneously Suppress NF-kB and Activate p53 by Targeting FACT.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 95, p. 1, doi. 10.1126/scitranslmed.3002530
- By:
- Publication type:
- Article
Core Facilities: Maximizing the Return on Investment.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 95, p. 1, doi. 10.1126/scitranslmed.3002421
- By:
- Publication type:
- Article
Cancer Drug Discovery Faces the FACT.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 95, p. 1, doi. 10.1126/scitranslmed.3002822
- By:
- Publication type:
- Article